AQP1 and colitis: At the same time, pharmacological treatment with sodium butyrate, a short-term fatty acid (SCFA) that is considered a fuel for intestinal epithelial cells, reverted the pathologic conditions, reducing the effect of colitis by normalizing AQP1 expression.